We are live on ! Find out more
CCG

Cypress Capital Group Portfolio holdings

AUM $889M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+27.23%
3 Year Est. Return
+83.89%
5 Year Est. Return
+113.23%
10 Year Est. Return
+324.61%
AUM
$890M
AUM Growth
+$55.4M
Cap. Flow
+$1.26M
Cap. Flow %
0.14%
Top 10 Hldgs %
33.32%
Holding
322
New
28
Increased
107
Reduced
160
Closed
12

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.27M
2
VZ icon
Verizon
VZ
+$1.21M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.14M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$964K
5
TXT icon
Textron
TXT
+$867K

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Healthcare 16.44%
3 Financials 10.2%
4 Consumer Discretionary 8.09%
5 Industrials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
226
Clorox
CLX
$11.6B
$456K 0.05%
2,799
-3,230
-54% -$479K
IPG
227
DELISTED
Interpublic Group of Companies
IPG
$452K 0.05%
14,287
-91
-0.6% -$2.79K
VB icon
228
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$449K 0.05%
1,894
PFF icon
229
iShares Preferred and Income Securities ETF
PFF
$13.3B
$448K 0.05%
13,471
-787
-6% -$25.3K
PRF icon
230
Invesco FTSE RAFI US 1000 ETF
PRF
$9.79B
$447K 0.05%
+11,000
New +$431K
VTR icon
231
Ventas
VTR
$48B
$443K 0.05%
6,913
-55
-0.8% -$3.21K
FAST icon
232
Fastenal
FAST
$54.7B
$439K 0.05%
12,300
-340
-3% -$11.5K
ETR icon
233
Entergy
ETR
$50.2B
$437K 0.05%
6,638
-308
-4% -$18.2K
TFC icon
234
Truist Financial
TFC
$63.3B
$436K 0.05%
10,186
+119
+1% +$5.03K
CEG icon
235
Constellation Energy
CEG
$93.8B
$429K 0.05%
1,651
+411
+33% +$81.7K
IWN icon
236
iShares Russell 2000 Value ETF
IWN
$14.3B
$428K 0.05%
2,566
-214
-8% -$34.8K
MRSH
237
Marsh
MRSH
$90.5B
$428K 0.05%
1,918
+24
+1% +$5.33K
HSY icon
238
Hershey
HSY
$35.5B
$423K 0.05%
2,207
-13
-0.6% -$2.53K
CVS icon
239
CVS Health
CVS
$133B
$418K 0.05%
6,654
+320
+5% +$18.7K
BSX icon
240
Boston Scientific
BSX
$69.5B
$401K 0.05%
4,784
+794
+20% +$62.6K
FISV
241
Fiserv Inc
FISV
$28.8B
$399K 0.04%
2,219
+11
+0.5% +$1.81K
NVS icon
242
Novartis
NVS
$297B
$398K 0.04%
3,458
+39
+1% +$4.42K
VWO icon
243
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$379K 0.04%
+7,913
New +$352K
IGSB icon
244
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$375K 0.04%
7,129
-186
-3% -$9.68K
EWY icon
245
iShares MSCI South Korea ETF
EWY
$21.9B
$374K 0.04%
5,850
REGN icon
246
Regeneron Pharmaceuticals
REGN
$78.5B
$372K 0.04%
354
+3
+0.9% +$3.34K
HYG icon
247
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$371K 0.04%
4,625
+200
+5% +$15.7K
LNT icon
248
Alliant Energy
LNT
$18.3B
$369K 0.04%
6,087
+44
+0.7% +$2.5K
XLI icon
249
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$367K 0.04%
2,706
-125
-4% -$15.9K
AVB icon
250
AvalonBay Communities
AVB
$26.5B
$359K 0.04%
1,594
-3
-0.2% -$648

Similar funds

Cypress Capital Group's Q3 2024 Portfolio in Review

As of Q3 2024, Cypress Capital Group held 322 positions worth $890M, up 6.6% from $834M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cypress Capital Group's Q3 2024 filing shows 28 new, 107 increased, 160 reduced and 12 closed positions. Its largest new stake was Advanced Micro Devices: 10,380 shares worth $1.7M. The largest sale was Eli Lilly, an estimated $1.27M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Cypress Capital Group's largest Q3 2024 buy was Advanced Micro Devices: 10,380 shares worth $1.7M.
  • Cypress Capital Group added most to Broadcom in Q3 2024, an estimated $1.37M increase.
  • Cypress Capital Group's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.27M.
  • Cypress Capital Group fully exited Textron in Q3 2024, selling an estimated $867K.
  • Cypress Capital Group's ten largest holdings make up 33% of its $890M portfolio in Q3 2024.
  • Cypress Capital Group opened 28 new positions and closed 12 in Q3 2024.
  • Cypress Capital Group's portfolio value rose 6.6% quarter-over-quarter to $890M.

Based on Cypress Capital Group's 13F filing for Q3 2024, filed 8 Nov 2024.